This study addresses a critical safety concern in regenerative medicine—the presence of residual undifferentiated pluripotent stem cells (PSCs) in cell therapy products (CTPs), which poses a risk of tumor formation.
Detection of residual pluripotent stem cells in cell therapy products utilizing droplet digital PCR: an international multisite evaluation study
STEM CELLS Translational Medicine, 2024